Pharma channel feed

Scoop: Ab­b­Vie, Bris­tol My­ers bring out the bud­get axe, out­lin­ing plans to lay off more than 350 West Coast em­ploy­ees

3 years ago
People

Catch­ing up with Mer­ck in ad­ju­vant melanoma, Bris­tol My­ers bur­nish­es Op­di­vo pro­file in ear­li­er stages of can­cer

3 years ago
R&D

Gilead aims to dri­ve health eq­ui­ty through ed­u­ca­tion eq­ui­ty with new $20M fund

3 years ago
Marketing

Illi­nois phar­ma com­pa­ny to pay al­most $8M af­ter sell­ing OTC drugs un­der ob­so­lete pre­scrip­tion-on­ly la­bels

3 years ago
Law

Sen­a­tors ques­tion how HHS plans to roll out new drug pric­ing re­forms

3 years ago
Law

As­traZeneca and peo­ple who are im­muno­com­pro­mised, in­clud­ing celebs, re­mind us they're 'still here’ in new Covid an­ti­body cam­paign

3 years ago
Marketing

Trou­bled times: With its back against the wall, lit­tle Tenax sends out an SOS while IMV takes out the bud­get axe, chops staff

3 years ago
People

FDA un­veils list of al­ter­na­tive ways to com­ply with cGMP re­quire­ments for com­bo prod­ucts

3 years ago
FDA+
Manufacturing

'Pluck­ing our way up that list': Bay­er high­lights on­col­o­gy am­bi­tions in new Kendall Square labs

3 years ago
R&D

Swiss reg­u­la­tors in­ves­ti­gate No­var­tis over 'un­law­ful abuse' of der­ma­tol­ogy patent

3 years ago
Law

Ninth Cir­cuit backs dis­trict court, toss­es Nexus Phar­ma ap­peal in com­pound­ing drug suit

3 years ago
Law

US gov­ern­ment pledges $2B for new ini­tia­tive on bio­man­u­fac­tur­ing

3 years ago
Manufacturing

Fed­er­al judge dis­miss­es kick­back claims in No­var­tis whistle­blow­er case — again

3 years ago
Law

Is Lil­ly plan­ning two brands for tirzepatide? CFO dis­cuss­es di­a­betes and obe­si­ty pos­si­bil­i­ties

3 years ago
Marketing

'Not To­day, Flu': Sanofi en­lists Se­in­feld star Ja­son Alexan­der to boost flu vac­ci­na­tions this fall

3 years ago
Marketing

CSL takes the wraps off a big new R&D cen­ter as it eyes vac­cines, cell and gene ther­a­pies

3 years ago
R&D

Ab­b­Vie un­veils 'See Your­self' Botox cam­paign, days af­ter new ri­val ap­proved

3 years ago
Marketing

Ab­b­Vie spon­sors on­line atopic der­mati­tis doc­u­men­tary de­but, re­veals new lifestyle da­ta

3 years ago
Marketing

As­traZeneca wins fed­er­al class-ac­tion suit, judge dis­miss­es share­hold­er­s' mis­lead­ing claims

3 years ago
Law

New gener­ics save pa­tients bil­lions per year, ac­cord­ing to FDA re­port

3 years ago
FDA+

Form 483 un­masks man­u­fac­tur­ing is­sues at Alvotech be­fore its CRL, and one for Au­robindo too

3 years ago
FDA+
Manufacturing

Mar­ket­ingRx roundup: Am­gen ‘sum­mer of sci­ence’ sun­sets In­sta­gram run; Pfiz­er vaults in­to top 10 of con­sumer loy­al brands

3 years ago
Marketing

So­cial me­dia meets sci­ence in ‘Lab Shenani­gans’ with Tik­Tok-fa­mous re­searcher — and some­times Pfiz­er part­ner

3 years ago
Marketing

'Re­al­ly in­clude every­one in the tri­al': A Q&A with the pro­to­col chair of the PhI­II mon­key­pox an­tivi­ral study

3 years ago
R&D
FDA+
First page Previous page 173174175176177178179 Next page Last page
A service from the Financial Times